Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

被引：0
|
作者：
Evan J Lipson
William H Sharfman
Shuming Chen
Tracee L McMiller
Theresa S Pritchard
January T Salas
Susan Sartorius-Mergenthaler
Irwin Freed
Sowmya Ravi
Hao Wang
Brandon Luber
Janice Davis Sproul
Janis M Taube
Drew M Pardoll
Suzanne L Topalian
机构：
[1] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Oncology
[2] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Oncology
[3] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Surgery
[4] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Dermatology
[5] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Division of Biostatistics and Bioinformatics, Department of Oncology
[6] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Pathology
来源：
Journal of Translational Medicine | / 13卷
关键词：
Melanoma; Vaccine; Immunotherapy; Adjuvant; GM-CSF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [1] Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
    Lipson, Evan J.
    Sharfman, William H.
    Chen, Shuming
    McMiller, Tracee L.
    Pritchard, Theresa S.
    Salas, January T.
    Sartorius-Mergenthaler, Susan
    Freed, Irwin
    Ravi, Sowmya
    Wang, Hao
    Luber, Brandon
    Sproul, Janice Davis
    Taube, Janis M.
    Pardoll, Drew M.
    Topalian, Suzanne L.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [2] A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients
    Barrio, Maria M.
    de Motta, Patricia T.
    Kaplan, Julio
    von Euw, Erika M.
    Bravo, Alicia I.
    Chacon, Reinaldo D.
    Mordoh, Jose
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (04) : 444 - 454
  • [3] Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine
    Kayaga, J
    Souberbielle, BE
    Sheikh, N
    Morrow, WJW
    Scott-Taylor, T
    Vile, R
    Dalgleish, AG
    GENE THERAPY, 1999, 6 (08) : 1475 - 1481
  • [4] Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine
    J Kayaga
    B E Souberbielle
    N Sheikh
    W J W Morrow
    T Scott-Taylor
    R Vile
    A G Dalgleish
    Gene Therapy, 1999, 6 : 1475 - 1481
  • [5] GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses
    Kwek, Serena S.
    Kahn, James
    Greaney, Samantha K.
    Lewis, Jera
    Cha, Edward
    Zhang, Li
    Weber, Robert W.
    Leonard, Lonnie
    Markovic, Svetomir N.
    Fong, Lawrence
    Spitler, Lynn E.
    ONCOIMMUNOLOGY, 2016, 5 (04):
  • [6] Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
    Parmiani, G.
    Castelli, C.
    Pilla, L.
    Santinami, M.
    Colombo, M. P.
    Rivoltini, L.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 226 - 232
  • [7] GVAX: an allogeneic, whole-cell, GM-CSF-secreting cellular immunotherapy for the treatment of prostate cancer
    Ward, James E.
    McNeel, Douglas G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1893 - 1902
  • [8] Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine
    SE Parker
    D Monteith
    H Horton
    R Hof
    P Hernandez
    A Vilalta
    J Hartikka
    P Hobart
    CE Bentley
    A Chang
    R Hedstrom
    WO Rogers
    S Kumar
    SL Hoffman
    JA Norman
    Gene Therapy, 2001, 8 : 1011 - 1023
  • [9] Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine
    Parker, SE
    Monteith, D
    Horton, H
    Hof, R
    Hernandez, P
    Vilalta, A
    Hartikka, J
    Hobart, P
    Bentley, CE
    Chang, A
    Hedstrom, R
    Rogers, WO
    Kumar, S
    Hoffman, SL
    Norman, JA
    GENE THERAPY, 2001, 8 (13) : 1011 - 1023
  • [10] Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
    Butterfield, Lisa H.
    Zhao, Fengmin
    Lee, Sandra
    Tarhini, Ahmad A.
    Margolin, Kim A.
    White, Richard L.
    Atkins, Michael B.
    Cohen, Gary I.
    Whiteside, Theresa L.
    Kirkwood, John M.
    Lawson, David H.
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5034 - 5043
1234